These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26623028)

  • 21. The effects of doxorubicin-loaded liposomes on viability, stem cell surface marker expression and secretion of vascular endothelial growth factor of three-dimensional stem cell spheroids.
    Lee H; Son J; Na CB; Yi G; Koo H; Park JB
    Exp Ther Med; 2018 Jun; 15(6):4950-4960. PubMed ID: 29805519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Placebo-controlled, randomized, evaluator-blinded endoscopy study of risedronate vs. aspirin in healthy postmenopausal women.
    Lanza FL; Rack MF; Li Z; Krajewski SA; Blank MA
    Aliment Pharmacol Ther; 2000 Dec; 14(12):1663-70. PubMed ID: 11121916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endoscopic comparison of esophageal and gastroduodenal effects of risedronate and alendronate in postmenopausal women.
    Lanza FL; Hunt RH; Thomson AB; Provenza JM; Blank MA
    Gastroenterology; 2000 Sep; 119(3):631-8. PubMed ID: 10982755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.
    Harris ST; Watts NB; Genant HK; McKeever CD; Hangartner T; Keller M; Chesnut CH; Brown J; Eriksen EF; Hoseyni MS; Axelrod DW; Miller PD
    JAMA; 1999 Oct; 282(14):1344-52. PubMed ID: 10527181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal osteoporosis.
    Sebba AI; Bonnick SL; Kagan R; Thompson DE; Skalky CS; Chen E; de Papp AE;
    Curr Med Res Opin; 2004 Dec; 20(12):2031-41. PubMed ID: 15706659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Applications of inflammation-derived gingival stem cells for testing the biocompatibility of dental restorative biomaterials.
    Soancă A; Lupse M; Moldovan M; Pall E; Cenariu M; Roman A; Tudoran O; Surlin P; Șorițău O
    Ann Anat; 2018 Jul; 218():28-39. PubMed ID: 29604386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risedronate inhibits bone marrow mesenchymal stem cell adipogenesis and switches RANKL/OPG ratio to impair osteoclast differentiation.
    Jin J; Wang L; Wang XK; Lai PL; Huang MJ; Jin DD; Zhong ZM; Chen JT; Bai XC
    J Surg Res; 2013 Mar; 180(1):e21-9. PubMed ID: 22487394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of
    Lee H; Uddin MS; Lee SW; Choi S; Park JB
    Exp Ther Med; 2017 Dec; 14(6):5696-5702. PubMed ID: 29285111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risedronate preserves bone architecture in early postmenopausal women in 1 year as measured by three-dimensional microcomputed tomography.
    Dufresne TE; Chmielewski PA; Manhart MD; Johnson TD; Borah B
    Calcif Tissue Int; 2003 Nov; 73(5):423-32. PubMed ID: 12964065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of osteoporosis by risedronate-- speed, efficacy and safety].
    Giljević Z; Vlak T
    Reumatizam; 2006; 53(2):66-71. PubMed ID: 17580558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review of risedronate in the treatment of osteoporosis.
    Geusens P; McClung M
    Expert Opin Pharmacother; 2001 Dec; 2(12):2011-25. PubMed ID: 11825332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elcatonin in combination with risedronate is more effective than risedronate alone for relieving back pain in postmenopausal women with osteoporosis.
    Takakuwa M; Iwamoto J
    Biol Pharm Bull; 2012; 35(7):1159-65. PubMed ID: 22791166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of antifracture drugs in postmenopausal, male and glucocorticoid-induced osteoporosis--usefulness of alendronate and risedronate.
    Iwamoto J; Takeda T; Sato Y
    Expert Opin Pharmacother; 2007 Nov; 8(16):2743-56. PubMed ID: 17956196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of risedronate on osteocyte viability and bone turnover in paired iliac bone biopsies from early postmenopausal women.
    Qiu S; Phipps RJ; Ebetino FH; Palnitkar S; Sudhaker Rao D
    Calcif Tissue Int; 2010 Nov; 87(5):392-7. PubMed ID: 20809096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis.
    Eriksen EF; Melsen F; Sod E; Barton I; Chines A
    Bone; 2002 Nov; 31(5):620-5. PubMed ID: 12477578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France.
    Hiligsmann M; Reginster JY
    Osteoporos Int; 2019 Mar; 30(3):649-658. PubMed ID: 30701342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risedronate for the prevention and treatment of postmenopausal osteoporosis.
    Cranney A; Waldegger L; Zytaruk N; Shea B; Weaver B; Papaioannou A; Robinson V; Wells G; Tugwell P; Adachi JD; Guyatt G
    Cochrane Database Syst Rev; 2003; (4):CD004523. PubMed ID: 14584020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 2-year phase II study with 1-year of follow-up of risedronate (NE-58095) in postmenopausal osteoporosis.
    Clemmesen B; Ravn P; Zegels B; Taquet AN; Christiansen C; Reginster JY
    Osteoporos Int; 1997; 7(5):488-95. PubMed ID: 9425508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risedronate once a week.
    White NJ; Perry CM
    Treat Endocrinol; 2003; 2(6):415-20; discussion 421. PubMed ID: 15981945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy.
    Wallach S; Cohen S; Reid DM; Hughes RA; Hosking DJ; Laan RF; Doherty SM; Maricic M; Rosen C; Brown J; Barton I; Chines AA
    Calcif Tissue Int; 2000 Oct; 67(4):277-85. PubMed ID: 11000340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.